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Abstract 
BACKGROUND: Toxoplasma gondii is a common parasitic infection of humans. Infection is usually mild. Serious 
complications can occur in pregnant and immunocompromised patients.  
AIM: The present study aims to investigate the performance of 2 different PCR protocols; real-time quantitative 
molecular assays (qPCR) and conventional molecular assays (cPCR), using 2 different sets of primers and by 
using cloned purified Toxoplasma genomic substances to be evaluated as reference samples.  
METHODS: The target DNA was provided in 8 different quantities.  
RESULTS: Amplification failure was reported only with the cPCR in samples of low concentrations using both 
primer sets. Quantitative PCR detected the 8 different dilutions of the purified Toxoplasma gondii using the 2 sets 
of primers while cPCR was sensitive to detect only 6 different dilutions.  
CONCLUSION: Generally real-time quantitative molecular assays, is easy to use method compared to 
conventional PCR assay and produces more reliable results within only one hour time but still the possible 
application of qPCRs in routine diagnosis necessitates analysis of a large number of clinical samples in further 
studies to make the proper choice. 
 
 
 
 
 
Introduction 
 
Toxoplasma gondii (T. gondii) is a known 
frequent cause of infection in a lot of warm-blooded 
animals including humans. This parasitic infection 
constantly infects between 15 and 85% of the world 
adult human population depending on geographical 
location. Fortunately, most cases of human infection 
are mild, but the severe disease may happen in 
immunocompromised individuals and congenitally 
infected fetuses in which serious complications may 
arise. Early diagnosis is crucial to start treatment that 
drastically reduces the extent of damage [1] [2]. 
Diagnosis of active infection using serology is often 
defective because reactivation of hidden infection is 
not all the time associated with changes in the levels 
of antibody, and evolution of latent or dormant 
toxoplasmosis is highly unpredictable. 
Furthermore, IgM detection does not 
necessarily specify recent infection [3] [4]. Parasite 
DNA detection by PCR was, therefore, considered in 
many types of research as a step forward to improve 
and accelerate toxoplasmosis diagnosis
 
by performing 
different PCR protocols including quantitative real-
time PCR (qPCR) which has been first reported by 
Bell & Ranford-Cartwright, [5]. These lately described 
real-time assays allow amplification and concurrent
 
DNA detection in one hour [6] [7] [8]. However, there 
is no available in vitro diagnostic molecular technique 
for parasitic infection, unlike many bacterial and viral 
infections. In general, there are various factors 
affecting the outcome of PCR including the targeted 
DNA, the selected primers, the choice of reference 
control in addition to the optimisation of other reaction 
condition [9]. Over 25 diverse primer pairs have been 
used in various assays, most of them aiming for the 
repetitive 35-copy-number B1 gene [10].  
Searching for optimal technique, this work 
aimed to investigate the performance of 2 different 
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PCR protocols; qPCR and conventional PCR (cPCR), 
using 2 different sets of primers and by using cloned 
purified Toxoplasma genomic substances to be 
evaluated as reference samples.  
 
 
Methods 
 
A cloned purified Toxoplasma DNA (Roche 
Diagnostics) was prepared according to the 
manufacturer’s recommendations. The target DNA 
was provided in 8 different quantities to yield from 10 
copies/rxn to 10
8
 copies/rxn of Toxoplasma gondii 
target molecules in 5 µl once dissolved. Start with the 
lowest concentration, a hole through the sealing foil 
was punched, and 45 µl PCR- grade water was added 
to each vial. The target DNA was then mixed by 
pipetting the solution up and down 10 times. For 
quantitative PCR, LightCycler FastStart DNA 
Master
PLUS
 Hybridization Probes
®
 Kit (Roche 
Diagnostics, Hoffmann-La Roche Ltd, USA) was used, 
applying Fluorescence Resonance Energy Transfer 
protocol (FRET PCR). For amplification, 5 µl of DNA 
was used for each reaction mixture. The resulting 
PCR fragment of T. gondii was analysed using 
software data analysis version 3.5.3 which was 
implemented as stated in the LightCycler
® 
instrument 
operator's manual. The reaction mixture (20 µl; Master 
PLUS
 Hybridization Probes
®
 kit; Roche Diagnostic) 
contained each primer 0.5 µM, MgCl2 5 mM and 5 µl
 
template DNA. Capillaries were tightly closed, 
centrifuged at 500 g for 5s, and was then amplified in 
a LightCycler
®
 instrument. Amplification for 50 cycles 
was performed: 5s denaturation at 95°C,
 
10s 
annealing at 61°C and 15s extensions at 72°C. The 
overall ramp rate was 20°C/s. One ﬂuorescence 
reading for each sample was recorded at the 
extension step. Results were quantitatively 
demonstrated by determination of the revealing 
threshold or the crossing point (Cp), which distinct the 
cycle when the ﬂuorescence of the used sample 
exceeded the baseline signal signiﬁcantly. Samples 
were demonstrated as a fractional cycle number. The 
two sets of Toxoplasma primers were; a) the RE 
region (GenBank accession number AF146527), a 
repetitive sequence of 200-300 repeats in the 
Toxoplasma genome, giving an amplified fragment of 
134 bp in conventional PCR; b) the commonly used 
B1 gene producing an amplified product of 432 bp. 
The adjusted conditions for conventional PCR 
(cPCR), were; 0.8 µl of every primer (50 pmol/µl), 20 
mmol/L dNTPs and 1.25 U recombinant Taq 
polymerase in 1 × PCR reaction buffer (50 mmol/L 
KCl and 10 mmol/L Tris-HCl, 1.5 mmol/L MgCl2, 0.1% 
Triton × 100). The total volume prepared for the 
reaction was 50 µl, including 5 µl of the individual 
DNA samples. The Q cycler Quanta Biotech thermal 
cycler was used for the conventional amplification 
using: 94°C for 2 min, followed by 30 cycles of 94°C 
for 1 min, 57°C for 2 min and 72°C for 3 min. For 
negative control, PCR mixture with no DNA
 
and with 
DNase-free water was used to
 
detect any cross-
contamination. 
 
 
Results 
 
Quantitative PCR detected the 8 different 
dilutions of the purified Toxoplasma gondii using the 2 
sets of primers. Figure 1 shows the results of using 
the cloned Toxoplasma DNA, all concentrations from 
10
1
 to 10
8
 were detected by qPCR. Quantitative 
genomic estimation of these positive samples in 
qPCR (Figure 1) ranged from 1.7x 10
1
 to 9 x 10
10
.  
 
Figure 1: Eight positive samples of qPCR, starting fluorescence 
emission at different cycles and 2 negative control samples 
 
Crossing points (Cps) showed different values 
ranged from 29.68 to 12.88 reflecting the different 
DNA quantities. Regarding cPCR, the amplified 
fragments were separated by gel electrophoresis at 
(432 bp for the B1 gene and 134 bp for RE region) as 
shown in Figure 2. From the 8 serially diluted purified 
samples included in the present study, conventional 
PCR was sensitive to detect 10
3
 copies while failed to 
detect the low concentrations of (10
1
) and (10
2
) with 
both primers targeting B1 gene or RE region. No PCR 
contamination was observed during the study, as 
confirmed by the constant negativity of negative 
controls.  
 
Figure 2: Lane 1 and 5 are negative control samples, M lanes are 
100bp DNA markers. Lane 2 and 3 are the positive samples of the 
B1 gene (432pb), 4 and 6 positive results for RE region (143bp)  
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Discussion 
 
Almost one-third of humans have
 
been 
exposed to T. gondii parasite. Latest estimates of the 
disease burden rank toxoplasmosis as a foodborne 
infection at the same level as salmonellosis or 
campylobacteriosis [1]. These increase the 
requirement of a sensitive quantitative diagnostic 
assay to check the severity of such parasitic infection 
in different clinical situations especially in high-risk 
groups. Lately, molecular techniques using 
LightCycler
®
 devices have been greatly improved and 
supported by flexible software technologies which 
expand their implementation on unique analytic 
parameters to diagnose a wide range of infectious 
agents. No molecular kits are available for regular 
diagnosis of toxoplasmosis, but only for research 
purposes [6]. In the present study, amplification failure 
was reported only with the cPCR in samples of low 
concentrations using the both primer sets. In general, 
the main advantages of real-time qPCR over cPCR 
assays as mentioned by the previous authors are as 
follow; (a) it is less labor-intensive, the test is done in 
one step, while in cPCR at least two steps are 
needed; (b) it is performed in a closed system with no 
need for post-PCR treatment and therefore reduce the 
risk of any contamination (c) the result of the 
quantitative PCR (after DNA extraction) can be given 
in less than one hour for FRET-based assay versus a 
minimum of 6 hours with the conventional PCR [3] 
[11]. The LightCycler
®
 device has additional 
advantages over the thermal cycler used in the 
conventional PCR, which is the quantitative evaluation 
of the products. Such numerical exploration of the 
parasite load may have prognostic implications during 
follow up after treatment of infected subjects and 
could thus verify the practicality in comparing different 
drug regimens. This was also reported in a review 
done by Lui et al., [11] concerning the different 
methods used for diagnosis of toxoplasmosis, he 
recorded that the real-time PCR can be used to 
evaluate the efficiency of treatment since the intensity 
of the infection can be estimated. As for all parasitic 
diseases, molecular diagnosis of toxoplasmosis is still 
not standardized. Due to the previously mentioned 
advantages of qPCR over conventional PCR, it seems 
highly possible that there will be an agreement on 
real-time PCR assays in the future. In a relatively 
recent study done by Santos et al., [12], qPCR was 
able to diagnose T. gondii in patients with uveitis, and 
they recorded the reliability of this assay in diagnosing 
toxoplasmic active focal necrotizing retinochoroiditis. 
However, such an agreement on the choice of the 
most suitable sequence to be amplified will be more 
challenging. The possible application of qPCRs in 
routine diagnosis necessitates analysis of a large 
number of clinical samples in further studies to make 
the proper choice. Certainly, the cost of the molecular 
assay and the reagents needed to extract the DNA 
template beside the choice between the conventional 
or qPCR techniques should be cautiously evaluated, 
excluding the cost of the PCR device instruments 
which may be bothering, however in the initial phase 
only  
To conclude, real-time quantitative molecular 
assays are easy to use method compared to 
conventional PCR assay and produces results more 
readily. However, the chosen target gene can very 
much affect the results of the PCR assays, as we 
checked. Protocols for Real-time PCR should be 
optimised and properly evaluated in a larger number 
of samples before being implemented as routine 
diagnostic methods. 
Nevertheless, these molecular tests certainly 
offer an alternative to conventional or even nested-
PCR for a fast, easy and accurate diagnosis of 
toxoplasmosis. Toxoplasma B1 the tandem-arrayed 
35-fold-repetitive gene is still a useful target which can 
be used for detection of Toxoplasma strains in clinical 
samples. Primers targeting RE region or other more 
repetitive genes seemed to be more sensitive. 
However, further comparative studies are 
recommended using a large number of suspected 
clinical samples to confirm variable sensitivities. 
Cloned Toxoplasma templates may facilitate easier 
and cleaner preparation of Toxoplasma reference 
samples especially when animal houses are defective 
in research or diagnostic laboratories. 
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